Parallax Volatility Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.81M | Buy |
+30,431
| New | +$1.77M | ﹤0.01% | 813 |
|
|
2025
Q3 | – | Sell |
-47,237
| Closed | -$2.21M | – | 1610 |
|
|
2025
Q2 | $2.19M | Buy |
+47,237
| New | +$2.32M | ﹤0.01% | 849 |
|
|
2025
Q1 | – | Sell |
-116,520
| Closed | -$6.79M | – | 1609 |
|
|
2024
Q4 | $6.59M | Buy |
+116,520
| New | +$6.51M | 0.01% | 723 |
|
|
2023
Q3 | – | Sell |
-185,180
| Closed | -$11.3M | – | 2300 |
|
|
2023
Q2 | $11.8M | Buy |
185,180
+156,794
| +552% | +$10.5M | 0.03% | 489 |
|
|
2023
Q1 | $1.97M | Buy |
+28,386
| New | +$2M | ﹤0.01% | 1245 |
|
|
2020
Q4 | – | Sell |
-184,739
| Closed | -$11.1M | – | 2477 |
|
|
2020
Q3 | $11.1M | Buy |
184,739
+138,516
| +300% | +$8.34M | 0.01% | 947 |
|
|
2020
Q2 | $2.72M | Sell |
46,223
-1,657,604
| -97% | -$99.1M | ﹤0.01% | 1342 |
|
|
2020
Q1 | $95M | Buy |
1,703,827
+1,703,350
| +357,096% | +$104M | 0.12% | 117 |
|
|
2019
Q4 | $31K | Sell |
477
-3,464
| -88% | -$198K | ﹤0.01% | 2261 |
|
|
2019
Q3 | $200K | Sell |
3,941
-16,931
| -81% | -$796K | ﹤0.01% | 1861 |
|
|
2019
Q2 | $947K | Sell |
20,872
-87,931
| -81% | -$4.1M | ﹤0.01% | 1298 |
|
|
2019
Q1 | $5.19M | Buy |
108,803
+54,397
| +100% | +$2.71M | 0.01% | 686 |
|
|
2018
Q4 | $2.83M | Sell |
54,406
-61,111
| -53% | -$3.28M | ﹤0.01% | 923 |
|
|
2018
Q3 | $7.17M | Buy |
+115,517
| New | +$6.86M | 0.01% | 580 |
|
|
2018
Q1 | – | Sell |
-38,240
| Closed | -$2.46M | – | 2336 |
|
|
2017
Q4 | $2.34M | Buy |
38,240
+24,067
| +170% | +$1.51M | ﹤0.01% | 874 |
|
|
2017
Q3 | $903K | Buy |
+14,173
| New | +$828K | ﹤0.01% | 1108 |
|
|
2017
Q1 | – | Sell |
-300,883
| Closed | -$16.5M | – | 3569 |
|
|
2016
Q4 | $17.6M | Buy |
+300,883
| New | +$16.4M | 0.03% | 301 |
|
|
2016
Q3 | – | Sell |
-12,442
| Closed | -$799K | – | 2896 |
|
|
2016
Q2 | $915K | Buy |
12,442
+8,541
| +219% | +$604K | ﹤0.01% | 1225 |
|
|
2016
Q1 | $249K | Sell |
3,901
-25,413
| -87% | -$1.6M | ﹤0.01% | 1686 |
|
|
2015
Q4 | $2.02M | Sell |
29,314
-18,710
| -39% | -$1.24M | ﹤0.01% | 1011 |
|
|
2015
Q3 | $2.84M | Buy |
48,024
+44,855
| +1,415% | +$2.85M | 0.01% | 863 |
|
|
2015
Q2 | $211K | Buy |
+3,169
| New | +$209K | ﹤0.01% | 1962 |
|
|
2015
Q1 | – | Sell |
-22,296
| Closed | -$1.4M | – | 4404 |
|
|
2014
Q4 | $1.32M | Buy |
+22,296
| New | +$1.26M | ﹤0.01% | 1322 |
|
|
2014
Q2 | – | Sell |
-93,978
| Closed | -$4.63M | – | 4046 |
|
|
2014
Q1 | $4.88M | Buy |
93,978
+83,153
| +768% | +$4.42M | 0.03% | 396 |
|
|
2013
Q4 | $575K | Sell |
10,825
-25,855
| -70% | -$1.32M | ﹤0.01% | 1017 |
|
|
2013
Q3 | $1.7M | Sell |
36,680
-22,801
| -38% | -$1M | 0.01% | 559 |
|
|
2013
Q2 | $2.66M | Buy |
+59,481
| New | +$2.58M | 0.01% | 532 |
|
Other funds holding BMY
VCM
VPM
Parallax Volatility Advisers's BMY Position: Q1 2026 in Review
Parallax Volatility Advisers opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 30,431 shares worth $1.81M. The stake represents ﹤0.01% of the portfolio and ranks #813 among its holdings. This is a return to the name: Parallax Volatility Advisers previously reported a position in BMY as recently as Q2 2025.
Parallax Volatility Advisers first reported a position in BMY in Q2 2013 and has held it in 27 quarters since. The position peaked at $95M in Q1 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Parallax Volatility Advisers held 30,431 shares of Bristol-Myers Squibb worth $1.81M as of Q1 2026.
- Bristol-Myers Squibb was a new Parallax Volatility Advisers position in Q1 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #813 holding.
- Parallax Volatility Advisers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 27 quarters since.
- Parallax Volatility Advisers's Bristol-Myers Squibb position peaked at $95M in Q1 2020.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.